Genelife Clinical Research Pvt. Ltd.

Genelife Clinical Research Pvt. Ltd. Your Trustworthy Partner in Product Development! Genelife offers an array of study management services that encompass the entire spectrum of clinical research.

Founded in 2010, Genelife Clinical Research stands as a distinguished Contract Research Organization (CRO) committed to providing a comprehensive range of Phase I-IV clinical research services to global pharmaceutical, biotech, and medical device companies. Operating across Europe, the USA, and Asia, we bring an extensive portfolio of expertise and innovative solutions to drive success in every pr

oject. Our comprehensive offerings include but are not limited to:

1. Project Management
2. Clinical Operations: Clinical Site Selection & Management, Clinical and Medical Monitoring
3. Data Management
4. Biostatistics
5. Medical Writing
6. Regulatory Services
7. Quality Audits
8. Pharmacovigilance Studies
9. Pre-Clinical Studies
10. Bio-Avalability and Equlvalance studies

With our extensive experience in clinical trial management, we stand uniquely positioned to provide unparalleled support to our sponsors. Our past accomplishments span from single-center Phase I trials to large-scale multinational Phase III trials, showcasing our versatility and depth of expertise. Genelife offers an amalgamation of performance, reliability, and demonstrated therapeutic experience that culminate in high-quality results. Our resourceful approach, coupled with a customer-centric ethos, guarantees the success of your projects. At Genelife, we don't merely provide services; we deliver outcomes that resonate. Genelife is your gateway to performance-driven solutions. With a track record of achievement, a commitment to innovation, and an unwavering dedication to client satisfaction, we are poised to deliver results that turn your projects into success stories. Join us as we embark on a journey of transformation in clinical research. Experience the Genelife difference – where excellence meets innovation, and partnership meets performance.

✨ Happy Deepawali from Genelife Clinical Research Pvt. Ltd.! ✨As we celebrate the Festival of Lights, may this Deepawali...
31/10/2024

✨ Happy Deepawali from Genelife Clinical Research Pvt. Ltd.! ✨

As we celebrate the Festival of Lights, may this Deepawali bring new hopes, brighter days, and endless prosperity to each of you. At Genelife, we are grateful for the support and trust of our clients, partners, and dedicated team members who illuminate our journey in clinical research every day.

Let’s continue to light the way for advancements in healthcare and a healthier future for all.

Wishing you a Deepawali filled with joy, peace, and abundance. 🌟

Happy Deepawali! 🪔
hashtag hashtag

09/10/2024

With over 13 years of expertise and the successful completion of more than 50 clinical trials, Genelife Clinical Research has solidified its reputation as a leading Contract Research Organization (CRO) in the field of small molecule clinical trials. Pharmaceutical companies, from global industry lea

24/09/2024

Since its inception in 2010, Genelife Clinical Research Pvt. Ltd.

22/09/2024

The major differences between the ICH-GCP guidelines and the draft GCP proposed by the CDSCO involve several substantial updates aimed at modernizing and enhancing clinical research practices in India:
1. The draft guidelines emphasize incorporating advanced digital health technologies, such as wearables and sensors, into clinical trials to improve data collection and research methodologies. This reflects a shift towards more tech-savvy approaches in data acquisition, which includes both electronic and paper tools​.
2. There are new definitions for concepts such as e-consent and decentralized clinical trials. The draft also introduces a focus on computerized systems validation, ensuring that these systems adhere to specified standards for data management and security controls​.
3. The proposed changes update guidelines on ethics, emphasizing conflicts of interest, compensation for research-related harm, and privacy concerns. Quality assurance sections retain much of their previous content but incorporate a risk-based approach to quality management​.
4. The draft guidelines also expand to cover newer areas of research like medical devices, stem cells, and nanoparticles, and include sections on academic clinical research, marginalized communities, and enhanced sponsor oversight and monitoring​.
These updates indicate a significant effort by CDSCO to align more closely with global standards while addressing the specific local needs.

16/09/2024

In the rapidly evolving landscape of healthcare, driven by remarkable advances in pharmaceutics and biotechnology, the need for precise, expertise-driven clinical research has never been more critical. Genelife Clinical Research, a leader in the field, is at the forefront of defining the pathways fo

At Genelife Clinical Research, we are dedicated to improving global health outcomes by addressing critical medical chall...
12/09/2024

At Genelife Clinical Research, we are dedicated to improving global health outcomes by addressing critical medical challenges. Sepsis, a life-threatening response to infection, claims millions of lives each year, and its impact can be devastating. It's imperative to recognize the early signs of sepsis and ensure timely medical intervention. Join Genelife Clinical Research Pvt. Ltd. in this crucial health initiative. Together, we can safeguard lives and reduce the global burden of sepsis. Let’s spread the word and ensure that both the public and healthcare professionals are equipped with the knowledge to respond swiftly to this medical emergency.

10/09/2024

In the ever-evolving landscape of business, the key to delivering exceptional outcomes lies in a deep understanding of customer needs. At Genelife Clinical Research Pvt.

03/09/2024

In the competitive and rapidly evolving world of clinical research, the ability to deliver high-quality results across diverse projects is what sets leaders apart from the rest. At Genelife Clinical Research Pvt.

Happy 78th Independence Day!On this historic day, as India celebrates 78 years of freedom from colonial rule, we at Gene...
14/08/2024

Happy 78th Independence Day!
On this historic day, as India celebrates 78 years of freedom from colonial rule, we at Genelife Clinical Research Pvt. Ltd. join the nation in honoring the sacrifices and resilience of those who fought for our independence. This day is not only a reminder of our past but also a beacon of hope for our future. As India moves closer to realizing its dream of becoming a developed nation, we are filled with a renewed sense of purpose and commitment to contributing to this great journey.
May this Independence Day inspire us all to work together towards a brighter, healthier, and more prosperous India.
Jai Hind!

14/07/2024

On behalf of Genelife Clinical Research Pvt. Ltd., we wish you and your loved ones a joyous and blessed Eid ul Adha! 🌙✨ ...
16/06/2024

On behalf of Genelife Clinical Research Pvt. Ltd., we wish you and your loved ones a joyous and blessed Eid ul Adha! 🌙✨ May this special occasion bring you happiness, peace, and prosperity. Eid Mubarak!

Address

Office No. 12, Ground Floor, Evershine Mall, Chincholi Bunder, New Link Road, Malad West
Mumbai
400064

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Website

http://www.gene-life.com/

Alerts

Be the first to know and let us send you an email when Genelife Clinical Research Pvt. Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Genelife Clinical Research Pvt. Ltd.:

Share